Cargando…
VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB Trials
BACKGROUND: Untreated advanced hepatocellular carcinoma (HCC) has an overall poor prognosis. Currently there are 2 ongoing prospective randomized controlled trials that are evaluating the efficacy and safety of sorafenib and selective internal radiation therapy (SIRT) with yttrium-90 resin microsphe...
Autores principales: | Gebski, Val, Gibbs, Emma, Gandhi, Mihir, Chatellier, Gilles, Dinut, Aurelia, Pereira, Helena, Chow, Pierce KH, Vilgrain, Valérie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332836/ https://www.ncbi.nlm.nih.gov/pubmed/28202430 http://dx.doi.org/10.2196/resprot.7016 |
Ejemplares similares
-
Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trial
por: Gandhi, Mihir, et al.
Publicado: (2016) -
Radioembolisation with yttrium‒90 microspheres versus sorafenib for treatment of advanced hepatocellular carcinoma (SARAH): study protocol for a randomised controlled trial
por: Vilgrain, Valérie, et al.
Publicado: (2014) -
Vespro della Beata Vergine
por: Monteverdi, Claudio, 1567-1643
Publicado: (1990) -
Vespro della beata Vergine
por: Monteverdi, Claudio, 1567-1643
Publicado: (1996) -
Vespro della Beata Vergine, 1610
por: Monteverdi, Claudio, 1567-1643
Publicado: (1994)